Latest Content

Experts highlight the need for tailored care strategies to address fertility, financial strain and survivorship challenges in younger adults with cancer.

Dr. Alexander Meves explains how the Merlin CP-GEP test uses molecular data to help melanoma patients safely avoid unnecessary lymph node surgeries.

A tongue cancer survivor and her oncologist discuss lasting side effects, daily management, self-advocacy and emerging treatment approaches.

Pediatric Cancer Research Foundation CEO Danielle Fragalla discusses the biological differences in pediatric cancer and the need for treatments designed for developing bodies.

Gotistobart reduced risk of death by 54% and doubled 12-month survival vs chemotherapy in advanced squamous NSCLC after prior treatment.

A newly approved all-oral combination for CLL offers patients a fixed-duration option, reducing clinic visits and expanding personalized care.

An expert explains ostomy bags and how new technologies are improving comfort and quality of life after colorectal cancer surgery.

Libtayo improved survival and safety outcomes vs chemotherapy in advanced NSCLC, with 23% of patients alive at six years in the EMPOWER-Lung 1 trial.

Dr. Reshma Jagsi discusses optimizing breast cancer care by safely de-escalating surgery and radiation using patient-centered communication

Physician Dr. Sheri Prentiss advocates for baseline measurements and proactive surveillance to detect and treat breast cancer-related lymphedema early.

New data highlight colorectal cancer rates in younger adults, emphasizing the need for earlier screening, symptom awareness and timely diagnosis.

Nuvalent submitted an NDA for neladalkib to the FDA for patients with previously treated ALK-positive non-small cell lung cancer, based on ALKOVE-1 trial data showing activity.

Histotripsy uses focused ultrasound to treat liver tumors without surgery, needles or radiation, offering a new non-invasive option for patients.